Dr. Kalil Al-Nassir, MD
What this data tells you about Dr. Al-Nassir
Dr. Kalil Al-Nassir is a pulmonary disease in Amarillo, TX, with 16 years in practice. Based on federal Medicare data, Dr. Al-Nassir performed 9,284 Medicare services across 6,413 unique beneficiaries.
Between the years covered by Open Payments, Dr. Al-Nassir received a total of $35,332 from 16 pharmaceutical and/or device companies across 88 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Al-Nassir is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,821 | $91 | $195 |
| Blood draw (venipuncture) | 828 | $8 | $10 |
| Complete blood count (CBC) with differential | 760 | $8 | $20 |
| Office visit, established patient (20-29 min) | 650 | $67 | $125 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 647 | $26 | $101 |
| Test to determine lung volumes using sensors | 647 | $37 | $61 |
| Test to examine how well the lungs exchange gases | 647 | $37 | $75 |
| Basic metabolic blood panel | 596 | $8 | $25 |
| Chest X-ray, 2 views | 413 | $17 | $55 |
| Injection, methylprednisolone acetate, 20 mg | 360 | $4 | $15 |
| Flu vaccine administration | 196 | $24 | $25 |
| Drug injection, under skin or into muscle | 193 | $11 | $37 |
| Flu vaccine, high-dose | 189 | $70 | $86 |
| Office visit, established patient, complex (40-54 min) | 186 | $131 | $224 |
| Bilirubin level, direct | 185 | $5 | $16 |
| Comprehensive metabolic blood panel | 182 | $10 | $37 |
| Test for exercise-induced lung stress | 160 | $25 | $90 |
| Pneumonia vaccine administration | 65 | $29 | $30 |
| Pneumococcal vaccine, 23-valent | 60 | $131 | $175 |
| Sleep study including heart rate, breathing, and sleep time | 48 | $84 | $287 |
| Measurement of antibody for assessment of autoimmune disorder, any method | 46 | $18 | $39 |
| Natriuretic peptide (heart and blood vessel protein) level | 39 | $38 | $89 |
| New patient office visit (45-59 min) | 39 | $124 | $216 |
| Sed rate test (inflammation marker) | 36 | $3 | $7 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | 36 | $71 | $100 |
| Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 35 | $34 | $75 |
| New patient office visit, complex (60-74 min) | 32 | $168 | $238 |
| Free thyroxine (T4) test | 27 | $9 | $26 |
| Thyroid stimulating hormone (TSH) test | 27 | $16 | $40 |
| Rheumatoid factor level | 24 | $6 | $45 |
| Measurement of antibody for rheumatoid arthritis assessment | 23 | $13 | $50 |
| Screening test for autoimmune disorder | 18 | $12 | $30 |
| Measurement of dna antibody, native or double stranded | 18 | $13 | $45 |
| Smoking and tobacco use intensive counseling, more than 10 minutes | 18 | $26 | $32 |
| Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets | 17 | $140 | $176 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 16 | $101 | $377 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (91%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for pulmonary disease in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Al-Nassir is a clinical cardiology specialist, with above-average Medicare volume (top 1% in TX), and high industry engagement (speaking/promotional, top 8%), with 16 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Al-Nassir experienced with office visit, established patient (30-39 min)?
Does Dr. Al-Nassir receive payments from pharmaceutical companies?
How do Dr. Al-Nassir's costs compare to other pulmonary diseases in Amarillo?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology